我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
3
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
2
66.7%
终止
1
33.3%
暂无批准数据
- Affluent Medical's SPHINX pilot study for the Artus artificial urinary sphincter in women is set to launch across Europe in H2 2025, following successful robotic-assisted implantation evaluations. - The company recently completed its DRY pilot study in men with 10 successful implantations, demonstrating 100% device activation and a positive safety profile. - Stress urinary incontinence affects over 400 million people globally, with women representing approximately 80% of cases, creating a significant market opportunity estimated to reach $4.3 billion by 2027.
